title: Multicentric reticulohistiocytosis: a systemic osteoclastic disease?
authors.affiliation: Boston University Medical Center, Boston, Massachusetts, USA.
authors.forename: Katerine A
authors.initials: KA
authors.lastname: Codriansky
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Rünger
authors.forename: Jag
authors.initials: J
authors.lastname: Bhawan
authors.forename: Alpdogan
authors.initials: A
authors.lastname: Kantarci
authors.forename: Eugene Y
authors.initials: EY
authors.lastname: Kissin
mesh_terms: D000328:Adult; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002357:Cartilage Diseases / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D015616:Histiocytosis, Non-Langerhans-Cell / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D010010:Osteoclasts / Q000473:pathology; D012218:Rheumatoid Nodule / Q000473:pathology; D012859:Sjogren's Syndrome / Q000150:complications*; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid